Literature DB >> 22306247

Silencing of FAD synthase gene in Caenorhabditis elegans upsets protein homeostasis and impacts on complex behavioral patterns.

Vania C Liuzzi1, Teresa A Giancaspero, Elisabetta Gianazza, Cristina Banfi, Maria Barile, Carla De Giorgi.   

Abstract

BACKGROUND: FAD synthase is a ubiquitous enzyme that catalyses the last step of FAD biosynthesis, allowing for the biogenesis of several flavoproteins. In humans different isoforms are generated by alternative splicing, isoform 1 being localized in mitochondria. Homology searching in Caenorabditis elegans leads to the identification of two human FAD synthase homologues, coded by the single copy gene R53.1.
METHODS: The C. elegans R53.1 gene was silenced by feeding. The expression level of transcripts was established by semi-quantitative RT-PCR. Overall protein composition was evaluated by two-dimensional electrophoresis. Enzymatic activities were measured by spectrophotometry and oxygen consumption by polarography on isolated mitochondria.
RESULTS: From R53.1 two transcripts are generated by trans-splicing. Reducing by 50% the transcription efficiency of R53.1 by RNAi results in a 50% reduction in total flavin with decrease in ATP content and increase in ROS level. Significant phenotypical changes are noticed in knock-down nematodes. Among them, a significant impairment in locomotion behaviour possibly due to altered cholinergic transmission. At biochemical level, impairment of flavoenzyme activities and of some KCN-insensitive oxygen-consuming enzymes is detected. At proteomic level, at least 15 abundant proteins are affected by R53.1 gene silencing, among which superoxide dismutases. CONCLUSION AND GENERAL SIGNIFICANCE: For the first time we addressed the existence of different isoforms of FAD-metabolizing enzymes in nematodes. A correlation between FAD synthase silencing and flavoenzyme derangement, energy shortage and redox balance impairment is apparent. In this aspect R53.1-interfered nematodes could provide an animal model system for studying human pathologies with alteration in flavin homeostasis/flavoenzyme biogenesis.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306247     DOI: 10.1016/j.bbagen.2012.01.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

Review 1.  Riboflavin transport and metabolism in humans.

Authors:  Maria Barile; Teresa Anna Giancaspero; Piero Leone; Michele Galluccio; Cesare Indiveri
Journal:  J Inherit Metab Dis       Date:  2016-06-06       Impact factor: 4.982

2.  Continuous and Discontinuous Approaches to Study FAD Synthesis and Degradation Catalyzed by Purified Recombinant FAD Synthase or Cellular Fractions.

Authors:  Piero Leone; Maria Tolomeo; Maria Barile
Journal:  Methods Mol Biol       Date:  2021

3.  Mimicking human riboflavin responsive neuromuscular disorders by silencing flad-1 gene in C. elegans: Alteration of vitamin transport and cholinergic transmission.

Authors:  Piero Leone; Maria Tolomeo; Elisabetta Piancone; Pier Giorgio Puzzovio; Carla De Giorgi; Cesare Indiveri; Elia Di Schiavi; Maria Barile
Journal:  IUBMB Life       Date:  2021-09-24       Impact factor: 4.709

4.  Remaining challenges in cellular flavin cofactor homeostasis and flavoprotein biogenesis.

Authors:  Teresa A Giancaspero; Matilde Colella; Carmen Brizio; Graziana Difonzo; Giuseppina M Fiorino; Piero Leone; Roderich Brandsch; Francesco Bonomi; Stefania Iametti; Maria Barile
Journal:  Front Chem       Date:  2015-04-22       Impact factor: 5.221

5.  The trimer interface in the quaternary structure of the bifunctional prokaryotic FAD synthetase from Corynebacterium ammoniagenes.

Authors:  Ana Serrano; María Sebastián; Sonia Arilla-Luna; Silvia Baquedano; Beatriz Herguedas; Adrián Velázquez-Campoy; Marta Martínez-Júlvez; Milagros Medina
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

Review 6.  Development of Novel Experimental Models to Study Flavoproteome Alterations in Human Neuromuscular Diseases: The Effect of Rf Therapy.

Authors:  Maria Tolomeo; Alessia Nisco; Piero Leone; Maria Barile
Journal:  Int J Mol Sci       Date:  2020-07-26       Impact factor: 5.923

7.  Alteration of ROS homeostasis and decreased lifespan in S. cerevisiae elicited by deletion of the mitochondrial translocator FLX1.

Authors:  Teresa Anna Giancaspero; Emilia Dipalo; Angelica Miccolis; Eckhard Boles; Michele Caselle; Maria Barile
Journal:  Biomed Res Int       Date:  2014-05-08       Impact factor: 3.411

8.  Riboflavin-Responsive and -Non-responsive Mutations in FAD Synthase Cause Multiple Acyl-CoA Dehydrogenase and Combined Respiratory-Chain Deficiency.

Authors:  Rikke K J Olsen; Eliška Koňaříková; Teresa A Giancaspero; Signe Mosegaard; Veronika Boczonadi; Lavinija Mataković; Alice Veauville-Merllié; Caterina Terrile; Thomas Schwarzmayr; Tobias B Haack; Mari Auranen; Piero Leone; Michele Galluccio; Apolline Imbard; Purificacion Gutierrez-Rios; Johan Palmfeldt; Elisabeth Graf; Christine Vianey-Saban; Marcus Oppenheim; Manuel Schiff; Samia Pichard; Odile Rigal; Angela Pyle; Patrick F Chinnery; Vassiliki Konstantopoulou; Dorothea Möslinger; René G Feichtinger; Beril Talim; Haluk Topaloglu; Turgay Coskun; Safak Gucer; Annalisa Botta; Elena Pegoraro; Adriana Malena; Lodovica Vergani; Daniela Mazzà; Marcella Zollino; Daniele Ghezzi; Cecile Acquaviva; Tiina Tyni; Avihu Boneh; Thomas Meitinger; Tim M Strom; Niels Gregersen; Johannes A Mayr; Rita Horvath; Maria Barile; Holger Prokisch
Journal:  Am J Hum Genet       Date:  2016-06-02       Impact factor: 11.025

9.  A vitamin-B2-sensing mechanism that regulates gut protease activity to impact animal's food behavior and growth.

Authors:  Bin Qi; Marina Kniazeva; Min Han
Journal:  Elife       Date:  2017-06-01       Impact factor: 8.140

Review 10.  Riboflavin Deficiency-Implications for General Human Health and Inborn Errors of Metabolism.

Authors:  Signe Mosegaard; Graziana Dipace; Peter Bross; Jasper Carlsen; Niels Gregersen; Rikke Katrine Jentoft Olsen
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.